ArticleFrontiers in molecular biosciences2022

The Value of H2BC12 for Predicting Poor Survival Outcomes in Patients With WHO Grade II and III Gliomas.

Jie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.